Biotage AB Moving Into Mass Directed Flash

Uppsala, Sweden, September 4, 2012 / B3C newswire / - Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, announces that Biotage is in late stage development with its partner Microsaic Systems plc of a fully integrated solution for Mass Directed Flash with Biotage's flagship flash purification system IsoleraTM. A presentation will be held at the JASIS meeting in Makuhari, Japan on 5th September, 2012. The new solution will become commercially available in early 2013.

"This is a game changer in flash purification that will allow chemists to significantly improve their work flow. We have high expectations on the forthcoming launch of this product that will further strengthen our purification business," says Toshiyuki Yachi, Vice President of Marketing. For further information visit www.biotage.com or call: in Europe +46 18 56 57 10, in North America toll free 1 800 446 4752, in Japan +81 422 28 1233, other areas please call +46 18 56 57 10.

About Biotage

Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. Customers include the world's top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, with offices in China, Japan, the United Kingdom, the United States and a worldwide network of distributors. Biotage has 272 employees with sales of 428.4 MSEK in 2011. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange.

For further press information from Biotage please contact:

James Churchill

Marketing Communications

Biotage GB Ltd

Distribution Way

Dyffryn Business Park

Ystrad Mynach

Hengoed, Wales CF82 7TS

United Kingdom

Tel: +44 (0)1443 811 849

Mobile: +44(0)7875484778

Email: james.churchill@biotage.com